Cargando…

Prospective mode of action of Ivermectin: SARS-CoV-2

The well-known anti-helminthic drug ivermectin (IVM) has been established as an example of drug repurposing for the management of SARS-CoV-2 infection. Various study has been done to understand the inhibitory mechanism of IVM against SARS-CoV-2 targets. Broadly, IVM has been categorized as a host-di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Vaishali M., Verma, Saroj, Masand, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Masson SAS. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607737/ https://www.ncbi.nlm.nih.gov/pubmed/36593981 http://dx.doi.org/10.1016/j.ejmcr.2021.100018

Ejemplares similares

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022)

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review
por: Zaidi, Asiya Kamber, et al.
Publicado: (2021)

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
por: Low, Zheng Yao, et al.
Publicado: (2022)

The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2
por: Saha, Joyanta Kumar, et al.
Publicado: (2021)

Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
por: Cobos-Campos, R, et al.
Publicado: (2021)

In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
por: García-Aguilar, Alejandra, et al.
Publicado: (2023)

RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
por: Zaidi, Asiya Kamber, et al.
Publicado: (2021)

The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
por: Jans, David A., et al.
Publicado: (2021)

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
por: Caly, Leon, et al.
Publicado: (2020)

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
por: de Melo, Guilherme Dias, et al.
Publicado: (2021)

A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
por: Patil, Vaishali M., et al.
Publicado: (2020)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2021)

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity
por: Eastman, Richard T., et al.
Publicado: (2023)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022)

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

RETRACTED: Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
por: Hill, Andrew, et al.
Publicado: (2021)

Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection
por: Ragó, Zsuzsanna, et al.
Publicado: (2023)

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
por: Uematsu, Takayuki, et al.
Publicado: (2023)

Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study
por: Masand, Vijay H., et al.
Publicado: (2020)

Estimation of anti-SARS-CoV-2 IgG titre among blood donors in Ranchi
por: Kumari, Sushma, et al.
Publicado: (2022)

Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2
por: Izumida, Mai, et al.
Publicado: (2022)

Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach
por: González-Paz, Lenin, et al.
Publicado: (2021)

Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
por: Galan, Luis Enrique Bermejo, et al.
Publicado: (2021)

Possible Beneficial Actions of Caffeine in SARS-CoV-2
por: Romero-Martínez, Bianca S., et al.
Publicado: (2021)

Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase
por: Oscanoa, Teodoro J., et al.
Publicado: (2022)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells
por: Dinesh Kumar, Nilima, et al.
Publicado: (2022)

A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
por: Tripathy, Satyajit, et al.
Publicado: (2020)

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
por: Li, Wenwei, et al.
Publicado: (2021)

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
por: Li, Wenwei, et al.
Publicado: (2022)

Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
por: Behera, Priyamadhaba, et al.
Publicado: (2021)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022)

Electrochemical sensors for the detection of SARS-CoV-2 virus
por: Kumar, Neeraj, et al.
Publicado: (2022)

Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions
por: Zhou, Lucas, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
por: Chiok, Kim R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmvh5e3966j2s425q1jp2f3rpd